Filing Details
- Accession Number:
- 0001645627-18-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-02 16:45:35
- Reporting Period:
- 2018-09-28
- Accepted Time:
- 2018-10-02 16:45:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 8,000 shares | Avg. Price: $0.05 | Total Value: $402.80 |
| Number of Shares After Transactions: | 25,978,898 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-28 | 1,000 | $0.05 | 25,971,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-28 | 1,000 | $0.05 | 25,972,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-28 | 1,000 | $0.05 | 25,973,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-28 | 1,000 | $0.05 | 25,974,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-28 | 2,000 | $0.05 | 25,976,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-28 | 2,000 | $0.05 | 25,978,898 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
